Radiographic Progression Free Survival in Metastatic Hormone Sensitive Prostate Cancer, The ARCHES Study
In this presentation from Dan Petrylak, MD discusses the recent ARCHES study and offers an insightful perspective into radiographic progression-free survival (rPFS), in prostate cancer.Source: UroToday.com
Yale Urology to host annual 2021 Bernard Lytton Visiting Professor Day
Yale Urology to host its annual Bernard Lytton Visiting Professor Day on Thursday, June 17. The 2021 Visiting Professor is Amy E. Krambeck, MD, Professor of Urology, Northwestern Medical. This year's seminar will be held virtually, and presentations begin starting at 8:00 am.
Yale Urology Celebrates Men’s Health Month and Stresses the Importance of Health Screenings for African American Men
June is Men’s Health Month. Health screenings for all men are critical for staying on top of their overall health. Most especially, African American men need to prioritize health screenings as this population is especially “at risk” for some penile- and prostate-related conditions, as well as obesity-related conditions.
Daniel Kellner, MD, performs 250th HoLEP procedure
Daniel Kellner, MD, Associate Professor of Clinical Urology, recently performed his 250th Holmium Laser Enucleation of the Prostate (HoLEP) procedure. HoLEP can provide relief to men who have been diagnosed with benign prostatic hyperplasia (BPH) and are experiencing difficulties urinating. helps men with enlarged prostates find relief with minimal side effects.
Yale Cancer Center and Smilow Cancer Hospital physicians recognized as Connecticut Magazine 'Best Doctors'
Connecticut Magazine has named 90 Yale Cancer Center and Smilow Cancer Hospital physicians to its 2021 Best Doctors guide. Published in the magazine’s June issue, the 'Best Doctors' list consists of more than 1,500 Connecticut physicians from nearly 40 medical specialties.
Yale Research to be Presented at 2021 ASCO Annual Meeting
Yale Cancer Center (YCC) and Smilow Cancer Hospital (SCH) scientists and clinicians are presenting research studies at the 2021 Annual Virtual Meeting of the American Society of Clinical Oncology (ASCO) June 4-8. This year’s scientific program will feature more than 200 oral presentations and 1,900 poster presentations in over 20 disease-based and specialty tracks.
Learning to lead: a new digital resource library for women faculty in medicine at Yale
The Women’s Leadership Resource Library launched online in April. The fully digital lending library, available to anyone with Yale Library access, includes books, podcasts, TED talks, online courses and other resources that address topics like building confidence, embracing vulnerability, knowing your worth, responding in crisis, and the soft skills needed to become an effective leader.
Westerly Hospital to perform its first robotic surgeries on Tuesday
Surgeons at Westerly Hospital were scheduled to perform two robotic surgeries Tuesday, the hospital’s first two uses of a new da Vinci Xi Surgical System offering patients a minimally invasive alternative to traditional surgery. L+M acquired the da Vinci Surgical System in 2013 and extended its use to urological procedures in 2018 after the arrival of a urology practice headed by Dr. Joseph Renzulli, director of urology for Yale New Haven Health’s Eastern Region, which includes L+M and Westerly hospitals.Source: The Day
New Westerly Hospital robot, the da Vinci Xi Surgical System, brings high-level care to the community
A newly acquired robotic machine will expand surgical capabilities at Westerly Hospital, provide a new option for a minimally invasive alternative to traditional open surgery, and serve as another avenue for patients to receive high-level care in their community, doctors say.Source: The Westerly Sun
Five Questions With: Dr. Joseph Renzulli
Dr. Joseph Renzulli, a longtime Rhode Island urologist and associate professor of urology at Yale School of Medicine, is taking on new roles as regional medical director and chief of urology at Westerly Hospital and Lawrence + Memorial Hospital in New London, Conn. Both facilities are owned by Yale New Haven Health, which recently announced Renzulli’s hiring. Renzulli discusses the move to a new health system, and his interest in continuing to offer cutting-edge and minimally invasive treatment for various types of urologic cancers.Source: Providence Business News
Petrylak Explores the Use of Maintenance Avelumab in Metastatic Bladder Cancer
During a virtual Targeted Oncology Case-Based Roundtable event, Daniel P. Petrylak, MD, professor of Medicine (Medical Oncology) and Urology, Yale School of Medicine, director, Prostate and Genitourinary Medical Oncology, and director, Prostate Cancer Translational Research Group, Yale Cancer Center, discussed the case of a 66-year-old woman with metastatic bladder cancer.Source: Targeted Oncology
Mentoring Our Emerging Leaders
Helping physicians to become more critical thinkers is just one of the core competencies taught in Yale School of Management’s Emerging Leaders Program (ELP). For the last six years, in collaboration with Yale Medicine and the Yale New Haven Health System, the two-year ELP program has provided intensive business training to Yale Urology faculty—an extraordinary opportunity not lost on its participants.
A Legendary Leader in Urology
Ask Robert Weiss, MD, to talk about what stands out over his 50-plus years in the field as a scientist, clinician, and beloved professor and he will tell you he loves the variety, and the way pediatric urology makes him think. But along with the intellectual, scientific, and technical challenges that come with the territory, the word that crops up most often as he describes his wide-ranging career is…fun!
Are Focal Therapies the Future of Prostate Cancer?
For men with lower-risk, localized prostate cancer, Preston Sprenkle, MD, and Raj Ayyagari, MD, combine their expertise to offer a minimally-invasive treatment options. Focal therapy treats only the cancerous parts of the prostate, leaving remaining tissue unharmed and preserving nearby nerves and organs along with the patient’s quality of life.